Hide Board Information

Show Board Information

Oncotelic Therapeutics Inc. OTLC

Board Mod: ScottMyers911

Asst Mods:

Last Post: 10/30/2025 4:46:48 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 14

Oncotelic Therapeutics Inc. (OTCMRKTS: OTLC) Stock Message Board

1. OTLC Company Profile

    

2. OTLC Time & Sales

    

3. OTLC Recent News

    

4. OTLC Filings

    

5. OTLC Financials

    

6. OTLC Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

70	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	10/30/2025 4:46:48 PM
69	Nanomedicine Innovations Transforming Oncology	NetworkNewsWire	10/29/2025 5:42:29 PM
68	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	10/28/2025 5:10:26 PM
67	Nanomedicine Breakthrough Technology Redefining	NetworkNewsWire	10/27/2025 4:30:24 PM
66	Nanomedicines Next Leap: Why Particle Size	NetworkNewsWire	10/21/2025 4:14:03 PM
65	NetworkNewsBreaks Oncotelic Therapeutics Inc.	NetworkNewsWire	10/17/2025 4:12:17 PM
64	Oncotelic Therapeutics Inc.s (OTLC) Sapu003:	NetworkNewsWire	10/08/2025 4:36:23 PM
63	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	10/08/2025 4:14:25 PM
62	Oncotelic Therapeutics Inc. (OTLC) Venture Sapu	NetworkNewsWire	10/01/2025 5:35:17 PM
61	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/24/2025 4:38:09 PM
60	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/22/2025 4:30:29 PM
59	Oncotelic Therapeutics Inc. (OTLC): Leadership	NetworkNewsWire	09/19/2025 3:59:47 PM
58	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/19/2025 3:48:49 PM
57	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/18/2025 5:00:56 PM
56	Oncotelic Therapeutics Inc. (OTLC) Champions	NetworkNewsWire	09/17/2025 5:38:54 PM
55	Advancing Cancer Research Brings New Hope for	NetworkNewsWire	09/17/2025 5:34:26 PM
54	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/16/2025 3:45:44 PM
53	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/12/2025 4:06:51 PM
52	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/10/2025 3:33:58 PM
51	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	09/04/2025 3:55:55 PM
50	Oncotelic Therapeutics Inc. (OTLC) Is One to	NetworkNewsWire	09/03/2025 4:50:42 PM
49	NetworkNewsBreaks Oncotelic Therapeutics,	NetworkNewsWire	08/28/2025 4:29:58 PM
48	Oncotelic Announces Release of Pet2DAO Tokens	panda448	04/05/2023 8:42:29 PM
47	Oncotelic Awarded BARDA Funding for Development	panda448	10/17/2022 6:48:26 PM
46	Oncotelic Announces Pipeline Presentation and IPO	panda448	06/15/2022 5:04:02 PM
45	ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS	panda448	05/23/2022 1:25:35 PM
44	Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as	panda448	05/04/2022 1:04:13 PM
43	Oncotelic Appoints Seymour Fein M.D. as Chief	panda448	05/04/2022 1:04:02 PM
42	Oncotelic; Announcing Successful Joint Venture	panda448	04/04/2022 4:19:15 PM
41	Oncotelic presentation at MedInvest	panda448	04/01/2022 2:21:28 PM
40	Oncotelic JV Financing:	panda448	03/21/2022 3:48:37 PM
39	Oncotelic; Looking at Industry Comparison for the	panda448	03/15/2022 7:42:49 PM
38	Oncotelic; Discussing the Company's Development	panda448	03/15/2022 7:40:57 PM
37	Oncotelic; Diving into the Company's Outlook for	panda448	03/15/2022 7:40:43 PM
36	Oncotelic to Present New Studies on its TGF-	panda448	03/10/2022 2:17:44 PM
35	Oncotelic; An Introduction to CFO Amit Shah & His	panda448	03/02/2022 6:00:46 PM
34	Oncotelic Initiates Phase 1 Trial Evaluating CA4P	panda448	01/05/2022 11:37:47 AM
33	Oncotelic Announces that ORF8 Mutations are	panda448	12/22/2021 11:34:33 AM
32	Oncotelics Dr. Anthony Maida to Present at 2nd	panda448	12/14/2021 12:07:13 PM
31	Mesothelioma Clinical Trial to Involve Drug	panda448	12/08/2021 7:37:25 PM
30	Oncotelic 2021 Q3 Report, Litchfield reiterates	panda448	12/07/2021 6:44:09 PM
29	Biotech Growth Stocks Set to Benefit from Rising	panda448	12/03/2021 7:26:03 PM
28	New Oncotelic Therapeutics Inc (OTLC) Stock	panda448	11/29/2021 6:33:47 PM
27	Oncotelic Therapeutics Inc (OTLC) stock news and	panda448	11/22/2021 7:55:18 PM
26	Oncotelic Announces Successful Completion of	panda448	11/16/2021 9:27:46 AM
25	Another TGF-beta acquisition- bode well for	panda448	11/10/2021 5:47:11 PM
24	$OTLC in immunotherapy space: Immunotherapy	panda448	11/05/2021 7:56:33 PM
23	ONCOTELIC ANNOUNCES UPDATE ON THE OT-101 CLINICAL	panda448	10/22/2021 8:15:01 PM
22	ONCOTELIC ACQUIRES FAST TO MARKET LATE-STAGE DRUG	panda448	10/05/2021 6:19:24 PM
21	OT-101 an antisense against TGF-2 for	panda448	09/29/2021 8:17:18 PM

Older

Recent Articles

• Corbus Pharmaceuticals Moves Forward with Public Offering
• S&P 500 Achieves Historic Winning Streak and Market Insights
• Key Challenges Highlighted by Michael Saylor for Growth Strategy
• Ecer.com Launches Innovative AI Marketplace Strategy for Trade
• Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
• DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
• Danske Bank Sees Positive Trends and Growth for 2025
• Sampo plc's Latest Share Buyback Program and Results
• Exciting Developments in Kudu Well Appraisal by BW Energy
• Aalberts N.V. Strengthens Position with GVT Acquisition
• Nxera Pharma's Innovations and Financial Report for 2025
• Nxera Pharma Expands Manufacturing to Meet Growing Demand for QUVIVIQ®
• Vistin Pharma Reports Strong Q3 Results and Market Growth
• Corbus Pharmaceuticals Sets Price for New Stock Offering
• Introducing a New Executive Team Member at Realkredit Danmark
• Aalberts Enhances Market Position Through Latest Acquisition
• Exploring the Future of Green Hydrogen Development
• Aker Solutions ASA Sees Revenue Boost in Third Quarter
• Aker Solutions Reports Strong Performance in Q3 2025
• Aker Solutions’ Record Growth and Promising Future Outlook
• Investigation Launched into Conduent's Major Data Breach Event
• Vallourec Secures Groundbreaking Contract for Deepwater Project
• Essential Patient Inquiries for Portable X-Ray Scheduling
• Exploring Affordable Coastal Living Alternatives Near Beaches
• Intensity Therapeutics Sees Dip After Surging to New Heights
• Marimekko's Strategic Growth and Operations in 2025
• SCOR Reports Impressive Q3 2025 Earnings and Growth Metrics
• SPIE Reports Robust Growth and Strategic Acquisitions in 2025
• Trifork Group Achieves 4.7% Revenue Growth in Q3 Growth Report
• Ekspress Grupp’s Revenue Growth and Future Strategies Unveiled
• Marimekko Sees Growth in Q3 Revenue and Profits for 2025
• Syensqo's Strategic Shift: Selling Oil & Gas Division to SNF
• Elis Expands its Reach in Germany with New Acquisition Deal
• Biotalys' EVOCA Biofungicide Nears EPA Approval, Changing Crop Protection
• Hyundai and NVIDIA Unite for Advanced AI Innovation
• Transforming Manufacturing: NVIDIA and SK Group's AI Collaboration
• NVIDIA and Samsung Launch Revolutionary AI Manufacturing Factory
• NVIDIA and South Korea Join Forces to Revolutionize AI Landscape
• Vallourec Secures Major Offshore Contract with TechnipFMC
• SCOR Achieves Remarkable Q3 2025 with Strong Net Income
• Realsee Partners with Linkhome to Transform Real Estate with AI
• Revolutionizing Retirement: How Physicians Are Investing Wisely
• Strengthening Global Ties: Leaders Discuss Future Cooperation
• Innovative Partnership Transforming Real Estate Through AI Technology
• ROTOBOOST Partners with Baowu for Green Steel Innovation
• Transform Your Learning with Talkmate's AI Language Agent
• Amazon's Impressive Earnings Drive Stock Surge and Future Growth
• Netflix Considers Acquisition of Warner Bros. Discovery Assets
• Pete Buttigieg Advocates for Accelerated Autonomous Vehicle Growth
• Mont Royal Resources Advances Dual Listing Plans on ASX, TSXV